Compare TVTX & LION Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TVTX | LION |
|---|---|---|
| Founded | N/A | 1997 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Movies/Entertainment |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.1B | 3.5B |
| IPO Year | 2013 | 2025 |
| Metric | TVTX | LION |
|---|---|---|
| Price | $45.81 | $13.40 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 13 | 9 |
| Target Price | ★ $40.62 | $11.89 |
| AVG Volume (30 Days) | 2.0M | ★ 3.7M |
| Earning Date | 05-04-2026 | 05-21-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 92.89 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $2,631,800,000.00 |
| Revenue This Year | $44.76 | N/A |
| Revenue Next Year | $35.51 | $22.98 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $13.88 | $5.65 |
| 52 Week High | $48.61 | $15.01 |
| Indicator | TVTX | LION |
|---|---|---|
| Relative Strength Index (RSI) | 58.73 | 57.81 |
| Support Level | $41.43 | $11.88 |
| Resistance Level | $48.60 | $15.01 |
| Average True Range (ATR) | 2.02 | 0.60 |
| MACD | -0.24 | -0.09 |
| Stochastic Oscillator | 65.70 | 49.55 |
Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN)-rare kidney disorders that often cause end-stage kidney disease. It is also advancing pegtibatinase, a novel investigational enzyme replacement therapy for the treatment of HCU, a genetic disorder caused by a deficiency in a pivotal enzyme essential to the body.
Lionsgate Studios Corp is a motion picture and television studio operations aligned with the STARZ premium subscription platform to bring a varied portfolio of entertainment to consumers around the world. The group has two reportable business segments: the Motion Picture and Television Production reportable segments. Motion Picture consists of the development and production of feature films, the acquisition of North American and world-wide distribution rights. Television Production consists of the development, production, and world-wide distribution of television productions, including television series, television movies and mini-series, and non-fiction programming.